Preclinical Evaluation and Pilot Clinical Study of 18F-AlF-labeled FAPI-Tracers for PET Imaging of Cancer Associated Fibroblasts

Kongzhen Hu,Junqi Li,Lijuan Wang,Yong Huang,Li Li,Shimin Ye,Yanjiang Han,Shun Huang,Hubing Wu,Jin Su,Ganghua Tang

DOI: https://doi.org/10.1016/j.apsb.2021.09.032

IF: 14.903

2022-01-01

Acta Pharmaceutica Sinica B

Abstract:Background The recent development of many different types of radiotracers that target the fibroblast activation protein (FAP) has been promising for tumor diagnosis. Here, we set out to develop 18F-labeled FAP tracers for cancer-associated fibroblast imaging and evaluated the potential of these tracers for clinical application. Methods The non-radioactive reference compounds and labeling precursors were synthesized using organic chemistry and the binding affinities were identified using surface plasmon resonance. Both radioligands (18F-P-FAPI and 18F-FAPI-42) were produced in an automated manner via complexation of Al18F. For in vitro characterization of 18F-P-FAPI and 18F-FAPI-42, we conducted studies to determine the partition coefficients, stability, cellular uptake, internalization, and efflux. In vivo biodistribution studies and microPET imaging of 18F-P-FAPI and 18F-FAPI-42, in comparison to 68Ga-FAPI-04, were conducted on the A549-FAP tumor bearing mice. Finally, one nasopharyngeal cancer patient underwent whole-body PET/CT after being injected with 18F-P-FAPI. Results Both 18F-P-FAPI and 18F-FAPI-42 were successful prepared with high specificity, rapid internalization, and potent affinity binding toward FAP. Compared to 18F-FAPI-42, 18F-P-FAPI exhibited lower levels of cellular efflux in the A549-FAP cells and higher stability in vivo. Furthermore, in vivo studies of 18F-P-FAPI in the A549-FAP tumor model indicated a higher tumor uptake than 18F-FAPI-42 and 68Ga-FAPI-04. An initial diagnostic application in patient with nasopharyngeal cancer, 18F-P-FAPI and 18F-FDG PET/CT showed comparable results for both primary tumors and lymph node metastases. Conclusion The radiofluorinated FAP-ligands demonstrated promising characteristics in their preclinical evaluation, and the feasibility of cancer-associated fibroblasts imaging was demonstrated using PET studies.